Skip to content
Open access

Targeted proteomics of postmortem human brain reveals neurobiologic heterogeneity in Alzheimer’s disease using NULISA technology

Jul 2026 · bioRxiv · 0 citations · 32 references
Biology Medicine

TL;DR

Proteomic differences in synapse integrity, tau post-translational modification, and ubiquitination associated with age at symptomatic onset and corticolimbic distribution of tangle pathology are observed.

Read PDF

Similar papers

Aug 2026

Association Between Postmortem Pathologic Burden and the Rate of Clinical Progression in Patients With Frontotemporal Lobar Degeneration.

Greater TDP-43 burden was most closely associated with antemortem clinical decline rather than cumulative aggregation through the disease course, suggesting that the temporal dynamics of protein aggregation may differ among FTLD proteinopathies, with implications for the interpretation of FTLD-Tau and FTLD-TDP‑specific...

R. Magee, Sharon X. Xie, DT Ohm et al. · 1 citation

Refining the genetic landscape of Alzheimer's disease : insights from a novel neuropathological cohort

This PhD project aimed to elucidate the genetic architecture of both hallmark and co-existing neuropathological features using a deeply phenotyped autopsy cohort of European ancestry, which provides novel insights into disease mechanisms and identifies potential targets for therapeutic intervention.

Celeste Laureyssen · 0 citations
Open access Aug 2026

An analysis of cerebral amyloid angiopathy based on samples from human brain bank

CAA is not simply an independent cerebrovascular disorder but also serves as a critical synergistic risk factor for Alzheimer’s disease neuropathologic change (ADNC) progression.

Yi-Zhou Zhang, Meng-Yao Ye, Shixiong Mi et al. · 0 citations
Open access Jul 2026

Clinicopathologic Evaluation of Amyloid Clearance in Alzheimer Disease

In this case report, areas of extensive amyloid clearance following amyloid targeting therapy were associated with less downstream neuropathological change and appear to preferentially occur in gyral crests.

Christopher A. Brown, John L. Robinson, Sandhitsu R. Das et al. · 0 citations
Review Open access Aug 2026

Advances in biomarker discovery for canine cognitive dysfunction: a comprehensive structured narrative review and future perspectives

Overall, the CCD biomarker landscape supports a multimodal approach integrating Aβ dysregulation, axonal injury, and glial activation, which will strengthen the translational value of CCD as a model for human dementia, accelerating discovery and therapeutic development across species.

Klysse Assumpção Barbosa, Heloísa Máximo Ribeiro, L. Benevenuto et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.